Court Challenges Brazil’s Pharmacy Data-for-Discount Model
A ruling against Drogasil questions whether retailers can make lower prices depend on customers handing over personal data.
A ruling against Drogasil questions whether retailers can make lower prices depend on customers handing over personal data.
GLP-1 weight-loss and diabetes drugs are reshaping RD Saúde’s business, positioning the retailer for a new cycle of data-driven growth.
Company opens 88 new stores, hits R$12.1 billion in sales and R$402 million in profit amid strong e-commerce momentum.